Long-term tolerability of fenretinide (4-HPR) in breast cancer patients

This publication has 19 references indexed in Scilit:

• Phase II study of Fenretinide (N-[4-Hydroxyphenyl]retinamide) in advanced breast cancer and melanoma
  Investigational New Drugs, 1990
• Ocular Toxic Effects of Fenretinide
  JNCI Journal of the National Cancer Institute, 1990
• Retinol, supplemental vitamin A and bone status
  Journal of Clinical Epidemiology, 1990
• Tolerability of the synthetic retinoid fenretinide® (HPR)
  European Journal of Cancer and Clinical Oncology, 1989
• An overview of the retinoids
  The American Journal of Medicine, 1989
• Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral Isotretinoin
  New England Journal of Medicine, 1988
• Bone density of the radius, spine, and proximal femur in osteoporosis
  Journal of Bone and Mineral Research, 1988
• Abnormal Retinal Function Associated With Fenretinide, a Synthetic Retinoid
  Archives of Ophthalmology (1950), 1986
• Phase I trial of retinol in cancer patients.
  Journal of Clinical Oncology, 1983
• Modulation of abnormal growth by retinoids: A clinical perspective of the biological phenomenon
  Life Sciences, 1981